July 13, 2020 9:33 am
Experts Explain ~ Drugs used in Covid-19 treatment: As cases and deaths rise, doctors have been trying out a range of treatments. Based on current evidence and what scientists say, here’s a compendium of what works (or doesn’t) — and in what specific circumstances
July 11, 2020 5:00 pm
Dexamethasone is proving to be far more effective in reducing the risk of death and can be made readily available to patients at affordable prices, writes Ganesan Karthikeyan.
July 08, 2020 10:29 am
"The idea that this is a dangerous drug is just silly, but if you ask the American people based on the media's coverage of it, that is kind of the state of play right now," White House Office of Trade and Manufacturing Policy Director Peter Navarro said.
June 30, 2020 2:55 pm
The Medicines and Healthcare Products Regulatory Agency (MHRA) took its decision on what is known as the COPCOV trial after hydroxychloroquine was found in another British trial to have no benefit as a treatment for patients already infected with COVID-19, the disease caused by the new coronavirus.
June 18, 2020 11:04 am
After Wednesday’s decision, investigators will not randomize further patients to hydroxychloroquine in the Solidarity trial. However, patients who have already started hydroxychloroquine but who have not yet finished their course in the trial may complete their course or stop at the discretion of the supervising physician, the WHO said.
June 16, 2020 8:56 am
The US Food and Drug Administration's (FDA) decision came on Monday after it concluded that the anti-malarial drugs may not be effective to cure the virus infections and lead to greater risks than any potential benefits.
June 15, 2020 11:38 pm
Citing reports of heart complications, the FDA said the drugs pose a greater risk to patients than any potential benefits.
June 14, 2020 7:22 am
Remdesivir, which is one of the most keenly watched in the search for a cure for the novel coronavirus disease, is part of the Word Health Organisation's ongoing Solidarity Trials, and it received emergency use authorisation by the United States Food and Drug Administration (USFDA) on May 1.
June 22, 2020 3:39 pm
After publishing a study raising questions on hydroxychloroquine’s efficacy against Covid-19, The Lancet has issued a retraction. What led to this, and what questions does it raise about the peer review process?
June 06, 2020 8:57 pm
Researchers have found that the drug hydroxychloroquine "with or without the antibiotic azithromycin" did not reduce the risk of ventilation or death, and was associated with longer length of hospital stay in COVID-19 patients.